Tag: $AGIO

Agios Pharma & Eleven Biotherepeutics driven by sentiments

AGIO – Agios Pharmaceuticals, Inc is a biopharmaceutical company, engaged in the discovery and development of medicines for the treatment of cancer and genetic disorders.

AGIO – Agios Pharmaceuticals, Inc

Fundamentals Previously closed at 50.35
Day’s high 55.96
Day’s low 50.02
P/E ratio NA
EPS -3.62

 

Analysts opinion Agios Pharma announced positive results for its phase 1 Drug AG-348, used to treat anaemia. The stock was upgraded by Canaccord Genuity and J. P Morgan to “Buy”. Analyst confidence meter, a proprietary algorithm of Stockal gives 66% buy based on analyst ratings.
Sentiments AGIO fell, after having gained 8% Pre-Market today. The sentiment index is 100% negative according to Stockal proprietary algorithm.
Social Media Pulse The stock has 10% lower social media chatter than usual.

Continue Reading…